1. Importance of Preclinical Studies in the Development of Drugs for Treatment of Osteoporosis: A Review Related to the 1998 WHO Guidelines

   • J.-P. Bonjour
   • P. Ammann
   • R. Rizzoli

   Review Article Pages: 379 - 393

2. An International Comparison of Serum 25-Hydroxyvitamin D Measurements

   • P. Lips
   • M. C. Chapuy
   • M. F. Holick

   Original Article Pages: 394 - 397

3. The Role of Serum TGF-β Isoforms as Potential Markers of Osteoporosis

   • D. J. Grainger
   • J. Percival
   • T. D. Spector

   Original Article Pages: 398 - 404

4. The Relationships Between the Degree of β-Isomerization of Type I Collagen Degradation Products in the Urine and Aging, Menopause and Osteoporosis with Fractures

   • H. Hoshino
   • M. Takahashi
   • T. Inoue

   Original Article Pages: 405 - 409

5. Image Analysis of the Distal Radius Trabecular Network Using Computed Tomography

   • B. Cortet
   • P. Dubois
   • X. Marchandise

   Original Article Pages: 410 - 419

6. Vertebral Bone Mineral Density, Content and Area in 8789 Normal Women Aged 33–73 Years Who Have Never Had Hormone Replacement Therapy

   • A. J. Shipman
   • G. W. G. Guy
   • R. Smith

   Original Article Pages: 420 - 426

7. Bone Density Measurements by Computed Tomography in Osteogenesis Imperfecta Type I

   • M. E. Miller
   • T. N. Hangartner

   Original Article Pages: 427 - 432

8. Relationship Between Structural Parameters, Bone Mineral Density and Fracture Load in Lumbar Vertebrae, Based on High-Resolution Computed Tomography, Quantitative Computed Tomography and Compression Tests

   • M. A. Haidekker
   • R. Andresen
   • H. J. Werner

   Original Article Pages: 433 - 440

9. Changes in Bone Density after Exposure to Oral Anticoagulants: A Meta-analysis

   • P. J. Caraballo
   • S. E. Gabriel
   • L. J. Melton III

   Original Article Pages: 441 - 448

10. Effects of Age, Menopause and Osteoporosis on Free, Peptide-Bound and Total Pyridinium Crosslink Excretion

    • M. T. Del Campo
    • M. L. González-Casaus
    • M. E. Martínez

    Original Article Pages: 449 - 454

11. Skeletal Benefits of Two Years of Alendronate Treatment Are Similar for Early Postmenopausal Asian and Caucasian Women

    • R. D. Wasnich
    • P. D. Ross
    • A. J. Yates

    Original Article Pages: 455 - 460

12. Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

    • H. A. P. Pols
    • D. Felsenberg
    • for the Fosamax® International Trial Study Group

    Original Article Pages: 461 - 468